Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Dec 07 • 03:42PM ET

96.65

Dollar change -0.94
Percentage change -0.96	%

Healthcare • Biotechnology • Denmark • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	23.68	EPS (ttm)	4.08	Insider Own	0.00%	Shs Outstand	3.42B	Perf Week	-5.10%
Market Cap	327.22B	Forward P/E	30.23	EPS next Y	3.20	Insider Trans	-	Shs Float	3.39B	Perf Month	-4.96%
Income	10.84B	PEG	8.46	EPS next Q	0.64	Inst Own	8.89%	Short Float / Ratio	0.18% / 1.24	Perf Quarter	-1.07%
Sales	30.79B	P/S	10.63	EPS this Y	47.04%	Inst Trans	-2.66%	Short Interest	5.97M	Perf Half Y	21.23%
Book/sh	2.97	P/B	32.57	EPS next Y	21.21%	ROA	29.06%	Target Price	104.63	Perf Year	53.67%
Cash/sh	2.00	P/C	48.42	EPS next 5Y	2.80%	ROE	93.02%	52W Range	62.41 - 105.69	Perf YTD	42.83%
Dividend	1.28	P/FCF	26.85	EPS past 5Y	8.17%	ROI	67.61%	52W High	-8.55%	Beta	0.41
Dividend %	1.32%	Quick Ratio	0.65	Sales past 5Y	8.19%	Gross Margin	84.16%	52W Low	54.86%	ATR	2.19
Employees	54393	Current Ratio	0.82	Sales Q/Q	39.02%	Oper. Margin	43.16%	RSI (14)	41.02	Volatility	1.34% 1.87%
Optionable	Yes	Debt/Eq	0.29	EPS Q/Q	-14.94%	Profit Margin	35.20%	Rel Volume	0.66	Prev Close	97.59
Shortable	Yes	LT Debt/Eq	0.21	Earnings	Nov 02 BMO	Payout	36.20%	Avg Volume	4.80M	Price	96.65
Recom	2.19	SMA20	-4.45%	SMA50	-1.46%	SMA200	11.83%	Volume	3,010,850	Change	-0.96%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-15-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-28-22	Downgrade	UBS	Neutral → Sell
Jun-27-22	Upgrade	Exane BNP Paribas	Underperform → Neutral
Jun-07-22	Upgrade	JP Morgan	Neutral → Overweight
May-31-22	Upgrade	Guggenheim	Neutral → Buy
Apr-25-22	Upgrade	Cowen	Market Perform → Outperform	$130
Apr-12-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Mar-16-22	Upgrade	Deutsche Bank	Hold → Buy
Jan-25-22	Downgrade	Liberum	Hold → Sell
Dec-20-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-17-21	Downgrade	Deutsche Bank	Buy → Hold
Jan-20-21	Downgrade	Credit Suisse	Outperform → Neutral
Jan-15-21	Initiated	Deutsche Bank	Buy
Sep-29-20	Initiated	Berenberg	Hold
Jul-06-20	Downgrade	BofA Securities	Buy → Neutral
May-11-20	Downgrade	UBS	Buy → Neutral
May-04-20	Initiated	Cowen	Market Perform	$72

Show Previous Ratings

Today 09:30AM	Is It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views? (Zacks)
Dec-05-23 01:45PM	Pfizers Weight-Loss Pill Disappointment Is an Opening for Biotech Rivals (Barrons.com)
12:00AM	Novo Nordisk seeks to use obesity drug findings to prevent weight gain (Financial Times)
Dec-04-23 06:14PM	8 Forces That Shaped 2023in Charts (Investopedia)
10:59AM	Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. Its Hoping to Compete with Eli Lilly, Novo Nordisk. (Barrons.com)
07:42AM	Loading…
07:42AM	Novo Nordisk A/S - share repurchase programme (GlobeNewswire)
Dec-03-23 06:54AM	3 No-Brainer Growth Stocks to Buy in December (Motley Fool)
Dec-02-23 09:30AM	Everyone Is Talking About This Stock. Is It a Good Long-Term Option? (Motley Fool)
05:53AM	Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk? (Motley Fool)
Dec-01-23 09:57AM	Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble? (Barrons.com)
08:51AM	Pfizer drops plan for twice-daily obesity pill due to side effects (Financial Times)
08:20AM	Will Novo Nordisk Be a Trillion-Dollar Stock by 2030? (Motley Fool)
07:43AM	UPDATE 3-EU watchdog seeks more data from GLP-1 drugmakers on suicidal thoughts (Reuters)
06:48AM	UPDATE 4-Pfizer drops twice-daily version of obesity pill over side effects (Reuters)
04:30AM	Worried About a Weight-Loss Stock Bubble? Here Are Some Alternatives. (Barrons.com)
10:48AM	Loading…
Nov-30-23 10:48AM	Weight loss drugs likely to boost apparel stocks: Survey (Yahoo Finance Video)
06:21AM	Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies (Reuters)
06:04AM	UPDATE 2-Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies (Reuters)
Nov-29-23 05:50AM	Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock? (Motley Fool)
01:25AM	15 Most Socialist States In The US (Insider Monkey)
Nov-28-23 06:59PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
04:38PM	UPDATE 1-Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon (Reuters)
04:05PM	Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives (Investor's Business Daily)
03:14PM	Is Eli Lilly Stock A Buy After Mounjaro Beats Out Ozempic In A Head-To-Head Analysis? (Investor's Business Daily)
02:17PM	Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon (Reuters)
09:24AM	Lillys Mounjaro Outperforms Novos Ozempic in Real-World Study (Barrons.com)
08:20AM	Forget Novo, Rolls-Royce Is Europes Best Stock This Year (Bloomberg)
Nov-27-23 11:51AM	George Soros and Jim Cramer Love These Stocks (Insider Monkey)
10:21AM	Weight loss drug maker plots buy now, pay later offer (The Telegraph)
09:00AM	Novo Nordisk A/S - share repurchase programme (GlobeNewswire)
08:15AM	Loading…
08:15AM	Midday movers: Affirm, Amazon, and More (Investing.com)
07:38AM	Wegovy maker Novo Nordisk could make prices flexiblewithout cutting themto persuade more health systems to cover the weight-loss drugs (Fortune)
07:05AM	Novo to expand French plant in GLP-1 production push (BioPharma Dive)
07:00AM	I want to scream: Jim Cramer is adamant that analysts are 'insane' to be so wary of revolutionary weight-loss drugs like Ozempic heres why the TV host is so bullish on these stocks (Moneywise)
03:40AM	Long-Time Novo Investor Cuts Stake Citing Weight-Loss Drug Hype (Bloomberg)
01:35AM	Novo Nordisk CEO: Willing to be "flexible" on Wegovy pricing schemes - FT (Investing.com)
Nov-26-23 11:00PM	Novo Nordisk looks at flexible pricing for obesity drug (Financial Times)
03:11PM	12 Best Diabetes Stocks To Buy Now (Insider Monkey)
02:00PM	Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout? (Motley Fool)
Nov-25-23 06:58AM	Could Ozempic Harm These 3 Medical Device Stocks? (Motley Fool)
Nov-24-23 01:34PM	New Highs: Novo Nordisk, PGT Innovations Among Best Stocks To Buy Now (Investor's Business Daily)
10:06AM	Eli Lilly and Novo Nordisk will remain winners in the weight-loss category: Barclays' Emily Field (CNBC TV)
09:30AM	Novo Nordisk (NVO) to Expand Manufacturing Site in France (Zacks)
07:23AM	Midday movers: Nvidia, iRobot, Coinbase and more (Investing.com)
Nov-23-23 01:29PM	Borrowing costs jump as traders unpick Hunt's Autumn Statement (The Telegraph)
12:15PM	Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site (Bloomberg)
11:02AM	Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France (GlobeNewswire)
09:56AM	UPDATE 3-Novo to launch Wegovy in Asia with February roll-out in Japan (Reuters)
09:26AM	$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years (Motley Fool)
09:06AM	20 Most Liberal Countries in the World (Insider Monkey)
08:54AM	Novo Nordisk to launch obesity drug Wegovy in Japan in February (Reuters)
07:04AM	UPDATE 3-Novo Nordisk invests $2.3 bln in France to boost obesity drug production (Reuters)
04:00AM	CORRECTED-UPDATE 2-Novo Nordisk invests $2.3 bln in France to boost obesity drug production (Reuters)
12:08AM	Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France (Reuters)
Nov-22-23 09:53PM	European stocks edge higher ahead of key PMI data, ECB minutes (Investing.com)
08:15AM	Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant (Motley Fool)
08:00AM	Thanksgiving: Travel, retail, market impact, and more (Yahoo Finance Video)
Nov-21-23 01:01PM	Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund (Reuters)
10:06AM	UPDATE 2-Novo rations Ozempic starter kits amid surge in use for weight loss (Reuters)
09:30AM	Is Novo Nordisk (NVO) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Nov-20-23 04:42PM	Eli Lilly Stock Nears Another Record As Drugmaker Enters The Weight-Loss Arena (Investor's Business Daily)
12:17PM	Thanksgiving: Will weight loss drugs impact holiday buying? (Yahoo Finance Video)
10:03AM	Novo Nordisk A/S - share repurchase programme (GlobeNewswire)
06:03AM	Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. (Motley Fool)
02:00AM	RPT-INSIGHT-How well-off Brits still buy Ozempic online for weight loss (Reuters)
02:00AM	RPT-EXPLAINER-Whats behind the scramble for semaglutide? (Reuters)
01:00AM	Wegovy craze was all the rage on Q3 earnings calls (Reuters)
Nov-19-23 06:05AM	Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock? (Motley Fool)
Nov-18-23 08:00AM	GE, Amazon Lead 5 Stocks Near Buy Points With This Bullish Trait (Investor's Business Daily)
06:01AM	EXPLAINER-Whats behind the scramble for semaglutide? (Reuters)
06:00AM	INSIGHT- How well-off Brits still buy Ozempic online for weight loss (Reuters)
Nov-17-23 05:30PM	Healthcare highlights: Amazon, YouTube, AI, weight loss drugs (Yahoo Finance Video)
03:05PM	Yahoo Finance's Healthcare Checkup: From Ozempic to to AI, how healthcare is changing (Yahoo Finance)
03:05PM	Yahoo Finance's Healthcare Checkup: From Ozempic to AI, how healthcare is changing (Yahoo Finance)
09:53AM	AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock (Motley Fool)
09:18AM	Eli Lilly Is Building a Plant in Germany to Meet Weight-Loss Drug Demand (Barrons.com)
08:45AM	Lilly to build $2.5 billion Germany plant as obesity drug demand soars (Reuters)
08:37AM	UPDATE 4-Lilly to build $2.5 billion Germany plant as obesity drug demand soars (Reuters)
08:03AM	Retail investors crowd into Eli Lilly after weight-loss drug approval (Reuters)
Nov-16-23 04:04PM	Novo Nordisk Eyes Another Breakout As Weight-Loss Battle Continues (Investor's Business Daily)
11:16AM	When to expect weight loss drugs to hit food, beverage sales (Yahoo Finance Video)
09:00AM	Better Growth Stock: Novo Nordisk vs. Eli Lilly (Motley Fool)
07:27AM	So many Americans are using Novo Nordisks blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug (Fortune)
Nov-15-23 06:00PM	Why Eli Lilly Stock Flopped While the Market Popped Today (Motley Fool)
04:32PM	Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates (Associated Press Finance)
03:51AM	UPDATE 3-German watchdog considers Ozempic export ban amid Europe shortages (Reuters)
01:30AM	Buffett's Berkshire Hathaway exits positions in some blue-chip stocks (Investing.com)
Nov-14-23 06:45PM	Investors increase holdings of weight-loss drug makers shares in Q3 -filings (Reuters)
04:05PM	Novo Nordisk's Ozempic Usage Suspended - Belgium Implements Temporary Ban Amid Medication Shortage (Benzinga)
01:04PM	Why some people may stop taking weight-loss drugs (Yahoo Finance Video)
11:37AM	Wegovy's Sales Potential Could Go Far Beyond Just Weight-Loss Treatment (Motley Fool)
10:00AM	3 Growth Stocks to Buy That Could Be Massive Long-Term Winners (Motley Fool)
09:54AM	11 Best Foreign Stocks To Buy Now (Insider Monkey)
09:45AM	Better Growth Stock: Pfizer vs. Novo Nordisk (Motley Fool)
07:45AM	Eli Lilly Is Planning to Dominate the Weight Loss Market and Make Billions. Here's Why It'll Keep Winning (Motley Fool)
06:07AM	Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons (GlobeNewswire)
Nov-13-23 09:50PM	Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks (Insider Monkey)
08:17PM	Jim Cramer weighs the market impact of Eli Lilly and Novo Nordisk's weight loss drugs (CNBC TV)
07:17PM	How Novo Nordisk's 'select' study results could shake up the obesity drug space (CNBC TV)
06:03PM	11 Best European Stocks To Buy Now (Insider Monkey)

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience